Remove 2021 Remove Homecare Remove Hospice companies
article thumbnail

How April Anthony, Investors Built New Home Health and Hospice Company VitalCaring

Hospice News

VitalCaring Group CEO April Anthony has a track record of building home-based care powerhouses, making her newest venture a company to watch as its emerging brand comes together. In 1999, she also established and led the health care tech firm Homecare Homebase. More transactions followed, with an emphasis on home health. NYSE: EHAB).

article thumbnail

As Headwinds Rage, Large Hospice Companies Lay Groundwork for Potential 2023 Growth

Hospice News

in the same period of 2021, according to research by Scott Fidel, analyst for Stephens. This has been a longstanding problem since the start of the pandemic, but average length of stay among the publicly traded firms tumbled at a faster rate in Q3 2022 (3%) than they did in the third quarter of 2021 (2%). The company saw a 10.6%

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Hospice News’ Top 10 Stories of 2022

Hospice News

In 2022, the hospice community laid the groundwork for a transformational 2023. During late 2021 and 2022, the U.S. Centers for Medicare & Medicaid Services (CMS) developed new approaches for enforcing hospice regulations that will become effective on Jan. 3–6 Big Provider, Payer Hospice Deals. s (NYSE: HUM) $2.8

2022 236
article thumbnail

5 Most Game-Changing Hospice Deals from 2022

Hospice News

The home health and hospice provider has had a “dominating” presence in the hospice M&A market in recent years, Mark Kulik, senior director at The Braff Group, previously told Hospice News. Humana retained Kindred’s home health assets, as well as 40% of the hospice business. This was Humana Inc.’s s (NYSE: HUM) $2.8

2022 229
article thumbnail

Hospice Multiples Unlikely to Drop

Hospice News

While a range of publicly traded companies and private equity firms have nevertheless snapped up hospices in record numbers, the skyrocketing valuations have led some to wait it out for a price drop. NYSE: CHEM), and the nation’s largest hospice company by market share, according to LexisNexis.

Hospice 202